Project Details
Description
Targeting drug-resistant breast cancers with allosteric cyclin-dependent kinase 2 inhibitors
| Status | Active |
|---|---|
| Effective start/end date | 9/1/24 → 8/31/25 |
Funding
- MAYO CLINIC ROCHESTER
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.